Development and Evaluation of an Innovative Neurology E-learning Didactic Curriculum for Psychiatry Residents
Academic Psychiatry · 2023
DOI: 10.1007/s40596-023-01769-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Psychiatry, 2023. Verfasst von Nuri Jacoby und 3 weiteren Autor:innen. Beteiligte Einrichtung: State University of New York (SUNY) Downstate Health Sciences University, Brooklyn, NY, USA. Nuri.jacoby@downstate.edu. Hauptthemen laut MEDLINE: Computer-Assisted Instruction, Internship and Residency, Neurology, Neuropsychiatry. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, American Board of Psychiatry and Neurology.
Abstract (Originalsprache)
OBJECTIVE: This article describes the development, implementation, and piloting of an e-learning neuropsychiatry curriculum for psychiatry residents. The primary outcome of interest was feasibility. Secondary outcomes were interest and confidence caring for patients with neuropsychiatric disorders, and knowledge about neuropsychiatry. METHODS: The curriculum was designed utilizing Kern's six-step framework. A ten-module, interactive, primarily vignette-based e-learning curriculum was developed focusing on the neurocognitive exam and neurocognitive disorders. The curriculum was piloted in two psychiatry residencies in Brooklyn, NY (n = 80 residents). The curriculum was evaluated using a survey adapted from the General Practitioner Attitudes and Confidence Scale for Dementia (GPACS-D) and a 24-item neuropsychiatry examination prior to the intervention and 1-month post-intervention. Qualitative feedback was acquired through four open-ended items in the post-curriculum survey, which underwent a thematic analysis. RESULTS: Seventy-eight of eighty residents completed the full curriculum. Three of nine attitude items demonstrated significant differences, with residents feeling less frustrated managing dementia (pre-mean = 2.32, post = 2.68, t(2,59) = 2.00, p = 0.004), less frustrated due to not knowing how to effectively treat dementia (pre-mean = 2.05, post = 2.95, t(2,59) = 6.27, p = 0.000), and demonstrating less interest in pursuing further training in neuropsychiatry (pre-mean = 1.95, post = 2.18, t(2,59) = 1.70, p = 0.047), though still overall showing interest. There was no change in confidence ratings. There was a small but significant improvement in total number of knowledge items answered correctly. CONCLUSIONS: This study demonstrated the feasibility of implementing an e-learning neuropsychiatry curriculum. It also demonstrated an improvement in resident responses to two attitude items and an increase in neuropsychiatry knowledge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State University of New York (SUNY) Downstate Health Sciences University, Brooklyn, NY, USA. Nuri.jacoby@downstate.edu.
- Maimonides Medical Center, Brooklyn, NY, USA. Nuri.jacoby@downstate.edu.
- University at Albany, State University of New York, Albany, NY, USA.
- State University of New York (SUNY) Downstate Health Sciences University, Brooklyn, NY, USA.
- Weill Cornell Medicine, New York, NY, USA.
Förderung
- NIA NIH HHS
- American Board of Psychiatry and Neurology
Zitieren
APA
Jacoby, N., Gullick, M., Sullivan, N., & Shalev, D. (2023). Development and Evaluation of an Innovative Neurology E-learning Didactic Curriculum for Psychiatry Residents. Academic Psychiatry. https://doi.org/10.1007/s40596-023-01769-7
Vancouver
Jacoby N, Gullick M, Sullivan N, Shalev D. Development and Evaluation of an Innovative Neurology E-learning Didactic Curriculum for Psychiatry Residents. Academic Psychiatry. 2023. doi:10.1007/s40596-023-01769-7
BibTeX
@article{Jacoby2023,
author = {Jacoby, Nuri and Gullick, Margaret and Sullivan, Nicholas and Shalev, Daniel},
title = {Development and Evaluation of an Innovative Neurology E-learning Didactic Curriculum for Psychiatry Residents},
journal = {Academic Psychiatry},
year = {2023},
doi = {10.1007/s40596-023-01769-7}
}
EUVIMED